W. B. Nelp

1.4k total citations
39 papers, 1.1k citations indexed

About

W. B. Nelp is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, W. B. Nelp has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in W. B. Nelp's work include Radiopharmaceutical Chemistry and Applications (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Nuclear Physics and Applications (6 papers). W. B. Nelp is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Nuclear Physics and Applications (6 papers). W. B. Nelp collaborates with scholars based in United States, South Africa and Italy. W. B. Nelp's co-authors include Janet F. Eary, Oliver W. Press, Paul J. Martin, Irwin D. Bernstein, Dana C. Matthews, K. A. Krohn, Bruce A. Porter, F. R. Appelbaum, Ted Gooley and S. Glenn and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Radiology.

In The Last Decade

W. B. Nelp

37 papers receiving 1.1k citations

Peers

Countries citing papers authored by W. B. Nelp

Since Specialization

Citations

This map shows the geographic impact of W. B. Nelp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. B. Nelp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. B. Nelp more than expected).

Fields of papers citing papers by W. B. Nelp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. B. Nelp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. B. Nelp. The network helps show where W. B. Nelp may publish in the future.

Co-authorship network of co-authors of W. B. Nelp

This figure shows the co-authorship network connecting the top 25 collaborators of W. B. Nelp. A scholar is included among the top collaborators of W. B. Nelp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. B. Nelp. W. B. Nelp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas 1995 ·The Lancet ·Oliver W. Press, F. R. Appelbaum, Paul J. Martin, Dana C. Matthews, Irwin D. Bernstein, Janet F. Eary, W. B. Nelp, Ted Gooley, S. Glenn, Bruce A. Porter, D.R Fisher	352
2	PRELIMINARY RESULTS OF A PHASE II TRIAL OF IODINE-131-LABELED ANTI-CD20 (B1) ANTIBODY THERAPY WITH BONE MARROW RESCUE FOR PATIENTS WITH RELAPSED B CELL LYMPHOMAS 1994 ·Journal of Immunotherapy ·Oliver W. Press, JF Eary, Peter J. Martin, F. R. Appelbaum, W. B. Nelp, Dana C. Matthews, DC Fisher, Irwin D. Bernstein	8
3	THE USE OF RADIOLABELED ANTI-CD33 ANTIBODY TO AUGMENT MARROW IRRADIATION PRIOR TO MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA 1992 ·Transplantation ·Frederick R. Appelbaum, Dana C. Matthews, Janet F. Eary, Christopher C. Badger, (unknown), Oliver W. Press, Paul J. Martin, Darrell R. Fisher, W. B. Nelp, E. Donnall Thomas, Irwin D. Bernstein	126
4	A Technetium-Labeled Monoclonal Antibody for Imaging Metastatic Melanoma 1991 ·American Journal of Clinical Oncology ·Stephen Frytak, Edward T. Creagan, M L Brown, Darrell Salk, W. B. Nelp	8
5	High dose radiolabeled antibody therapy of lymphoma. 1990 ·PubMed ·(unknown), Janet F. Eary, (unknown), Oliver W. Press, (unknown), (unknown), K. A. Krohn, W. B. Nelp, Bruce A. Porter, Darrell R. Fisher	25
6	Staging non-small cell carcinoma of the lung using technetium-99m-labeled monoclonal antibodies. 1990 ·PubMed ·Stanford B. Friedman, K. Sullivan, Darrell Salk, W. B. Nelp, (unknown), (unknown), Michael J. Blend, Ralph W. Aye, (unknown), Paul G. Abrams	15
7	Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. 1989 ·Journal of Clinical Oncology ·Oliver W. Press, Janet F. Eary, C Badger, Paul J. Martin, F R Appelbaum, Ronald Levy, R. A. Miller, S Brown, W. B. Nelp, K. A. Krohn	219
8	Technetium-99m Labeled Monoclonal Antibodies in the Detection of Metastatic Melanoma 1989 ·Clinical Nuclear Medicine ·A. N. Serafini, Jon Kotler, Lynn G. Feun, Mrinal K. Dewanjee, (unknown), Darrell Salk, George N. Sfakianakis, Paul G. Abrams, (unknown), David A. Goodwin, W. B. Nelp	10
9	Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. 1987 ·PubMed ·W. B. Nelp, Janet F. Eary, (unknown), K. E. Hellström, (unknown), Paul L. Beaumier, K. A. Krohn	28
10	Local muscle blood flow and temperature responses to 915MHz diathermy as simultaneously measured and numerically predicted. 1984 ·PubMed ·K. Michael Sekins, Justus F. Lehmann, Peter C. Esselman, (unknown), A. F. Emery, Barbara J. deLateur, W. B. Nelp	75
11	The need for routine delayed radionuclide hepatobiliary imaging in patients with intercurrent disease. 1984 ·Radiology ·(unknown), W. B. Nelp, (unknown)	10
12	A patient with polycythemia. 1981 ·PubMed ·John E. Olerud, (unknown), Kenneth F. Hossack, W. B. Nelp, (unknown), (unknown), C. A. Finch	3
13	Quantitation of Bone Mass in Osteoporosis: Recent Advances 1976 ·PubMed ·C. H. Chesnut, W. B. Nelp, T.K. Lewellen	1
14	Nuclear medicine techniques in the evaluation of post menopausal osteo porosis 1976 ·C. H. Chesnut, W. B. Nelp, T.K. Lewellen	4
15	Body composition determination by measurement of total body activation products in expired air 1974 ·OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) ·H.E. Palmer, T.K. Lewellen, Charles Chestnut, W. B. Nelp, J.L. Duggan, I.L. Morgan	2
16	Argon-37 excretion in humans following total-body neutron activation 1974 ·Transactions of the American Nuclear Society ·T.K. Lewellen, W. B. Nelp, H.E. Palmer	2
17	A high pressure noncatalytic method for cyclotron production of fluorine-18 1971 ·The International Journal of Applied Radiation and Isotopes ·(unknown), W. B. Nelp, (unknown)	5
18	Instrumentation for in Vivo Neutron Activation Analysis in Humans 1970 ·IEEE Transactions on Nuclear Science ·H.E. Palmer, (unknown), (unknown), W. B. Nelp, Robert Murano	2
19	MEASURING TOTAL BODY CALCIUM BY IN VIVO NEUTRON ACTIVATION ANALYSIS. 1969 ·Transactions of the American Nuclear Society ·W. B. Nelp, Robert Murano, (unknown), H.E. Palmer, Charles L. Rich, (unknown), (unknown), (unknown)	1
20	Distribution and Excretion of Technetium in Humans 1966 ·Health Physics ·T.M. Beasley, H.E. Palmer, W. B. Nelp	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact